Du, R., Xiao, N., Han, L., Guo, K., Li, K., Chen, Z., . . . Bian, H. (2024). Dexrazoxane inhibits the growth of esophageal squamous cell carcinoma by attenuating SDCBP/MDA-9/syntenin-mediated EGFR-PI3K-Akt pathway activation. Nature Portfolio.
Cita Chicago (17th ed.)Du, Ruijuan, et al. Dexrazoxane Inhibits the Growth of Esophageal Squamous Cell Carcinoma by Attenuating SDCBP/MDA-9/syntenin-mediated EGFR-PI3K-Akt Pathway Activation. Nature Portfolio, 2024.
Cita MLA (9th ed.)Du, Ruijuan, et al. Dexrazoxane Inhibits the Growth of Esophageal Squamous Cell Carcinoma by Attenuating SDCBP/MDA-9/syntenin-mediated EGFR-PI3K-Akt Pathway Activation. Nature Portfolio, 2024.
Atenció: Aquestes cites poden no estar 100% correctes.